12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant movement in Friday's after-market session. Gainers included NuCana (NCNA), Neuronetics (STIM), AIM ImmunoTech (AIM), Baudax Bio (BXRX), Nemaura Medical (NMRD), and Virax Biolabs Group (VRAX). Losers included PHAXIAM Therapeutics (PHXM), Synlogic (SYBX), Aveanna Healthcare Hldgs (AVAH), Syros Pharmaceuticals (SYRS), China Pharma Holding (CPHI), and SAB Biotherapeutics (SABS).
August 11, 2023 | 9:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AIM ImmunoTech's stock rose 9.49% to $0.64.
The significant increase in AIM ImmunoTech's stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Baudax Bio's shares moved upwards by 8.38% to $0.63.
The significant increase in Baudax Bio's stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
NuCana's stock rose 17.3% to $0.84 during Friday's after-market session.
The significant increase in NuCana's stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Nemaura Medical's stock increased by 8.1% to $0.88.
The significant increase in Nemaura Medical's stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Neuronetics' stock rose 10.22% to $1.94.
The significant increase in Neuronetics' stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Virax Biolabs Group's shares rose 8.1% to $0.4.
The significant increase in Virax Biolabs Group's stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Aveanna Healthcare Hldgs' stock decreased by 8.16% to $1.69.
The significant decrease in Aveanna Healthcare Hldgs' stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
China Pharma Holding's shares fell 7.21% to $0.23.
The significant decrease in China Pharma Holding's stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
PHAXIAM Therapeutics' stock declined by 8.9% to $0.51.
The significant decrease in PHAXIAM Therapeutics' stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
SAB Biotherapeutics' stock fell 5.43% to $0.76.
The significant decrease in SAB Biotherapeutics' stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Synlogic's stock decreased by 8.3% to $0.49.
The significant decrease in Synlogic's stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Syros Pharmaceuticals' shares decreased by 8.12% to $3.51.
The significant decrease in Syros Pharmaceuticals' stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100